Comparative Pharmacology
Head-to-head clinical analysis: LOKELMA versus SODIUM POLYSTYRENE SULFONATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: LOKELMA versus SODIUM POLYSTYRENE SULFONATE.
LOKELMA vs SODIUM POLYSTYRENE SULFONATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Patiromer, a non-absorbed potassium-binding polymer, exchanges calcium for potassium ions in the gastrointestinal tract, thereby increasing fecal potassium excretion and lowering serum potassium levels.
Sodium polystyrene sulfonate is a cation-exchange resin that exchanges sodium ions for potassium ions in the gastrointestinal tract, primarily in the large intestine, thereby reducing serum potassium levels.
5 g (one packet) orally three times daily; titrate to maintain serum potassium 4.0-5.0 mEq/L; maximum 15 g three times daily (45 g/day).
Adults: 15 g orally once daily to four times daily, as a single dose or suspension in water or syrup (3-4 mL per gram of resin). May also be administered rectally as a retention enema: 30-50 g every 6-8 hours, retained for at least 30-60 minutes.
None Documented
None Documented
Not applicable as LOKELMA is not systemically absorbed; terminal half-life is not measurable in traditional sense. Clinical effect duration correlates with gastrointestinal transit time (~6-8 hours for peak potassium lowering).
The terminal elimination half-life of the absorbed fraction is not well-defined due to minimal systemic absorption; hence, half-life is not clinically relevant. The resin itself is not eliminated from the body via metabolism or excretion but is passed in feces.
Primarily eliminated unchanged in feces (approximately 90%) via gastrointestinal transit; <1% excreted in urine as absorbed sodium zirconium cyclosilicate is negligible.
Primarily fecal (via gut) as the resin is not absorbed. Only a small fraction (approximately 0.5-1% of the administered dose) is absorbed, and the absorbed portion is eliminated renally as the sulfonate moiety. Renal elimination contributes minimally to total clearance (<1%).
Category C
Category C
Potassium Binder
Potassium Binder